【TAIPEI, September 12, 2025】— Topmunnity Therapeutics Taiwan Limited, a company focused on biopharmaceutical development, today proudly announced that its AI new drug development project has been successfully selected for the 4th call for projects for "Taipei-1," a joint initiative by the Ministry of Economic Affairs and NVIDIA. This milestone not only highlights the national recognition of the company's technical strength but also injects strong momentum into its core technologies, accelerating its mission to build long-term competitiveness through innovation and excellence.

​

NVIDIA Taipei-1 is Taiwan's first AI supercomputer and the first AI supercomputer built by NVIDIA in Asia, designed to provide a world-class computing platform for academic research and industrial innovation.

​

Topmunnity Therapeutics CEO, Chao-Yua Huang, stated: "We are extremely grateful for the support from the Ministry of Economic Affairs and NVIDIA. Our self-developed platform, which focuses on functional antibody drug design, requires immense parallel computing resources. Gaining access to Taipei-1's top-tier computing power is a crucial step for us to accelerate our path toward the fusion era of Biotech and TechBio. Through this world-class supercomputer, we will be able to significantly enhance the efficiency of AI-generated antibodies and apply this technology to the design of functional antibodies (such as optimizing antibody-drug conjugates (ADCs)), bringing more treatment options to cancer patients."

​

The technical core of this project will leverage Taipei-1's powerful computing capabilities to establish a "large-scale protein database" to solve the "hallucination" problem in the AI-generated drug process, improving the quality and success rate of drug candidates.

​

Looking ahead, high-performance computing is turning what was once considered impossible in the biomedical field into reality. Topmunnity will integrate AI and machine learning to open up a new era in precision drug development.

 

​

About Topmunnity Therapeutics Taiwan Limited

Topmunnity Therapeutics Taiwan Limited is a company dedicated to the deep integration of artificial intelligence and biomedicine. Through its proprietary AI platform and advanced drug development pipeline, it aims to solve the pain points of traditional drug development and provide more effective and precise next-generation solutions for cancer treatment.

​​​

​

Media Contact:

Andrea Yang

Finance Manager

info@topmunnity.com

+886-2-2301-2180

www.topmunnity.com